7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-1H-quinolin-2-one;4-methoxy-2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-4-morpholin-4-ylquinolin-7-ol;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-4-pyrrolidin-1-ylquinolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3-propan-2-ylquinolin-7-ol
C154H204N32O10 — CID 158882594
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-1H-quinolin-2-one;4-methoxy-2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-4-morpholin-4-ylquinolin-7-ol;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-4-pyrrolidin-1-ylquinolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3-propan-2-ylquinolin-7-ol
7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-1H-quinolin-2-one;4-methoxy-2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-4-morpholin-4-ylquinolin-7-ol;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-4-pyrrolidin-1-ylquinolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3-propan-2-ylquinolin-7-ol (PubChem CID 158882594) has the molecular formula C154H204N32O10 and a molecular weight of 2663.54 g/mol. Its IUPAC name is 7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-1H-quinolin-2-one;4-methoxy-2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-4-morpholin-4-ylquinolin-7-ol;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-4-pyrrolidin-1-ylquinolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3-propan-2-ylquinolin-7-ol.
Molecular Properties
| Compound Name | 7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-1H-quinolin-2-one;4-methoxy-2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-4-morpholin-4-ylquinolin-7-ol;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-4-pyrrolidin-1-ylquinolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3-propan-2-ylquinolin-7-ol |
|---|---|
| PubChem CID | 158882594 |
| Molecular Formula | C154H204N32O10 |
| Molecular Weight | 2663.54 g/mol |
| Exact Mass | 2661.64 |
| IUPAC Name | 7-hydroxy-1-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-2-one;7-hydroxy-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-1H-quinolin-2-one;4-methoxy-2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]quinolin-7-ol;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-4-morpholin-4-ylquinolin-7-ol;2-methyl-6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-4-pyrrolidin-1-ylquinolin-7-ol;6-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]pyridazin-3-yl]-3-propan-2-ylquinolin-7-ol |
| SMILES | CC(C)c1cnc2cc(O)c(-c3ccc(N(C)C4CC(C)(C)NC(C)(C)C4)nn3)cc2c1.CN(c1ccc(-c2cc3ccc(=O)[nH]c3cc2O)nn1)C1CC(C)(C)NC(C)(C)C1.CN(c1ccc(-c2cc3ccc(=O)n(C)c3cc2O)nn1)C1CC(C)(C)NC(C)(C)C1.COc1cc(C)nc2cc(O)c(-c3ccc(N(C)C4CC(C)(C)NC(C)(C)C4)nn3)cc12.Cc1cc(N2CCCC2)c2cc(-c3ccc(N(C)C4CC(C)(C)NC(C)(C)C4)nn3)c(O)cc2n1.Cc1cc(N2CCOCC2)c2cc(-c3ccc(N(C)C4CC(C)(C)NC(C)(C)C4)nn3)c(O)cc2n1 |
| InChI | InChI=1S/C28H38N6O2.C28H38N6O.C26H35N5O.C25H33N5O2.C24H31N5O2.C23H29N5O2/c1-18-13-24(34-9-11-36-12-10-34)20-14-21(25(35)15-23(20)29-18)22-7-8-26(31-30-22)33(6)19-16-27(2,3)32-28(4,5)17-19;1-18-13-24(34-11-7-8-12-34)20-14-21(25(35)15-23(20)29-18)22-9-10-26(31-30-22)33(6)19-16-27(2,3)32-28(4,5)17-19;1-16(2)18-10-17-11-20(23(32)12-22(17)27-15-18)21-8-9-24(29-28-21)31(7)19-13-25(3,4)30-26(5,6)14-19;1-15-10-22(32-7)18-11-17(21(31)12-20(18)26-15)19-8-9-23(28-27-19)30(6)16-13-24(2,3)29-25(4,5)14-16;1-23(2)13-16(14-24(3,4)27-23)28(5)21-9-8-18(25-26-21)17-11-15-7-10-22(31)29(6)19(15)12-20(17)30;1-22(2)12-15(13-23(3,4)27-22)28(5)20-8-7-17(25-26-20)16-10-14-6-9-21(30)24-18(14)11-19(16)29/h7-8,13-15,19,32,35H,9-12,16-17H2,1-6H3;9-10,13-15,19,32,35H,7-8,11-12,16-17H2,1-6H3;8-12,15-16,19,30,32H,13-14H2,1-7H3;8-12,16,29,31H,13-14H2,1-7H3;7-12,16,27,30H,13-14H2,1-6H3;6-11,15,27,29H,12-13H2,1-5H3,(H,24,30) |
| InChIKey | JDFFLOHEBZWTKQ-UHFFFAOYSA-N |
| XLogP | 25.95 |
| TPSA | 499.04 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 41 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 196 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2663.54 |
| LogP ≤ 5 | 25.95 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 41 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158882594 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.